Profile: Echo Therapeutics, Inc. is a transdermal medical device and specialty pharmaceuticals company. We offer transdermal continuous glucose montioring (tCGM) systems for people with diabetes and advanced topical reformulations of FDA-approved specialty pharmaceuticals. Symphony™ tCGM System is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring system used for people with diabetes and for use in hospital critical care units. It includes the Prelude™ SkinPrep System for optimal skin ablation control. Our AzoneTS™ is an effective, nontoxic, penetration enhancer for use in transdermal drug delivery. It is known to increase lipid membrane fluidity in the stratum corneum, thereby decreasing the diffusion resistance to topically applied therapeutics. Durhalieve™ is also a transdermal product. It is used for the treatment of corticosteroid-responsive dermatoses.